VMP 39731611000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Almotriptan 12.5mg tablets
BNF code 0407041B0AAAAAA
Virtual Therapeutic Moiety Almotriptan
Date identifier became valid 27 May 2021
Previous product identifier 134531009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Almotriptan hydrogen malate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 363569003
Strength value numerator 12.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Almotriptan 12.5mg tablets (A A H Pharmaceuticals Ltd)
Almotriptan 12.5mg tablets (Accord-UK Ltd)
Almotriptan 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Almotriptan 12.5mg tablets (Healthcare Pharma Ltd)
Almotriptan 12.5mg tablets (Medihealth (Northern) Ltd)
Almotriptan 12.5mg tablets (Sigma Pharmaceuticals Plc)
Almotriptan 12.5mg tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Almotriptan 12.5mg tablets 12 tablet
Almotriptan 12.5mg tablets 3 tablet
Almotriptan 12.5mg tablets 6 tablet
Almotriptan 12.5mg tablets 9 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.0.0_20241202000001, imported on 3rd December 2024 at 03:57:46.

Feedback